<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-levothyroxine.xml</id>
  <title>Recalls Watch: Levothyroxine</title>
  <link rel="self" href="https://recalls.watch/feed/substance-levothyroxine.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-10-28T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99963/</id>
    <title>Pfizer: Levoxyl and 1 more</title>
    <link href="https://recalls.watch/recall/fda/99963/"/>
    <updated>2026-10-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99584/</id>
    <title>ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 11 more</title>
    <link href="https://recalls.watch/recall/fda/99584/"/>
    <updated>2026-09-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99399/</id>
    <title>Major Pharmaceuticals: Levothyroxine Sodium Tablets and 11 more</title>
    <link href="https://recalls.watch/recall/fda/99399/"/>
    <updated>2026-07-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99194/</id>
    <title>ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets</title>
    <link href="https://recalls.watch/recall/fda/99194/"/>
    <updated>2026-07-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98510/</id>
    <title>MACLEODS PHARMA USA, INC: Levothyroxine Sodium Tablets USP 150 mcg</title>
    <link href="https://recalls.watch/recall/fda/98510/"/>
    <updated>2026-04-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98225/</id>
    <title>Alvogen, Inc: Levothyroxine Sodium Tablets</title>
    <link href="https://recalls.watch/recall/fda/98225/"/>
    <updated>2026-01-21T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97613/</id>
    <title>ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets</title>
    <link href="https://recalls.watch/recall/fda/97613/"/>
    <updated>2025-10-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97334/</id>
    <title>Pfizer: Levoxyl</title>
    <link href="https://recalls.watch/recall/fda/97334/"/>
    <updated>2025-08-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97103/</id>
    <title>ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 6 more</title>
    <link href="https://recalls.watch/recall/fda/97103/"/>
    <updated>2025-07-23T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug: Assay below the approved specification</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96979/</id>
    <title>Macleods Pharmaceuticals Ltd: Levothyroxine Sodium Tablets</title>
    <link href="https://recalls.watch/recall/fda/96979/"/>
    <updated>2025-06-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of a foreign substance: black hair found embedded in tablet.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96666/</id>
    <title>ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 3 more</title>
    <link href="https://recalls.watch/recall/fda/96666/"/>
    <updated>2025-05-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96428/</id>
    <title>Mylan Institutional, Inc.: Levothyroxine Sodium Tablets and 1 more</title>
    <link href="https://recalls.watch/recall/fda/96428/"/>
    <updated>2025-03-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Super-Potent Drug: Out of specification potency results were obtained.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95892/</id>
    <title>Lupin Pharmaceuticals Inc.: Levothyroxine Sodium Tablets</title>
    <link href="https://recalls.watch/recall/fda/95892/"/>
    <updated>2025-01-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95817/</id>
    <title>Mylan Institutional, Inc.: Levothyroxine Sodium Tablets and 5 more</title>
    <link href="https://recalls.watch/recall/fda/95817/"/>
    <updated>2024-12-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent and Superpotent Drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95768/</id>
    <title>Viatris Inc: Levothyroxine Sodium Tablets USP and 10 more</title>
    <link href="https://recalls.watch/recall/fda/95768/"/>
    <updated>2024-12-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Superpotent Drug and Subpotent Drug: potency failures obtained</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95747/</id>
    <title>ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets</title>
    <link href="https://recalls.watch/recall/fda/95747/"/>
    <updated>2024-12-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent drug</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93202/</id>
    <title>AbbVie Inc.: Synthroid</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93202"/>
    <updated>2023-11-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.</summary>
  </entry>
</feed>
